Health impact of the total ban on advertising of tobacco products
The objective was to estimate the health impact of the total ban on advertising of tobacco products in terms of avoided cardiovascular events in those over 35 years of age in Argentina.
The Cardiovascular Disease Policy Model (CVDPM) was used, which is a Markov simulation model used to represent and project mortality and morbidity due to cardiovascular disease (CVD) in the population aged 35 or over. It constitutes a demographic-epidemiological model, which represents the population between 35 and 95 years of age and uses a logistic regression model based on the Framingham equation to estimate the annual incidence of cardiovascular disease. We assumed that implementing a complete ban on the advertising of tobacco products would lead to a 9% reduction in tobacco consumption.
The complete ban on advertising could prevent 15,164 deaths over a period of 10 years, of which 2610 would be the result of coronary heart disease and 747 due to stroke. These reductions would mean an annual decrease of 0.46% of total deaths, 0.60% of deaths from coronary heart disease and 0.33% in deaths from stroke. In addition, during the same period, it would avoid 6630 acute myocardial infarctions and 2851 strokes (reductions of 1.35% and 0.40%, respectively).
We hope that these findings might contribute to the strengthening of sanitary tobacco control policies in Argentina based on the remarkable benefits of banning the advertising of tobacco products in full and in line with current global recommendations.
AldereteEGregorichSEMontebanMKaplanCPMejiaRLivaudais-TomanJ, et al. Effect of appreciation for Indigenous cultures and exposure to racial insults on alcohol and drug use initiation among multiethnic Argentinean youth. Prev Med. 2016; 85: 60–68.
2.
National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. The tobacco industry’s influences on the use of tobacco among youth. In: Preventing Tobacco Use Among Youth and Young Adults: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention (US); 2012. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK99238/
3.
BenowitzNL.Nicotine addiction. N Engl J Med. 2010; 362: 2295–2303.
LavackAMTothG.Tobacco point-of-purchase promotion: examining tobacco industry documents. Tob Control. 2006 Oct;15(5):377–84. PubMed PMID: 16998172. Pubmed Central PMCID: 2563651.
6.
PaynterJEdwardsR.The impact of tobacco promotion at the point of sale: a systematic review. Nicotine & Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobacco. 2009; 11: 25–35.
LovatoCWattsASteadLF.Impact of tobacco advertising and promotion on increasing adolescent smoking behaviours. Cochrane Database Syst Rev. 2011; 10: CD000165.
9.
Boletín Oficial de la República Argentina. Ley 26.687 Regulación de la publicidad, promoción y consumo de los productos elaborados con tabaco. Buenos Aires2011.
10.
SafferHChaloupkaF.The effect of tobacco advertising bans on tobacco consumption. J Health Econ. 2000; 19: 1117–1137.
11.
World Health Organization, Research for International Tobacco Control. WHO Report on the Global Tobacco Epidemic. The MPOWER package. World Health Organization;2008.
12.
WeinsteinMCoxsonPWilliamsLPassTStasonWGoldmanL.Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model. Am J Public Health. 1987; 77: 1417–1426.
13.
KonfinoJMekonnenTACoxsonPGFerranteDBibbins-DomingoK.Projected impact of a sodium consumption reduction initiative in Argentina: an analysis from the CVD policy model - Argentina. PLoS One. 2013; 8: e73824.
14.
FerranteDKonfinoJMejíaRCoxsonPMoranAGoldmanL, et al. Relación de la costo utilidad de la disminución del consumo de sal y su efecto en la incidencia de enfermedades cardiovasculares en la Argentina. Rev Panam Salud pública. 2012; 32: 274–280.
15.
MoranADeGennaroVFerranteDCoxsonPPalmasWMejíaR, et al. Coronary heart disease and stroke attributable to major risk factors is similar in Argentina and the United States: the Coronary Heart Disease Policy Model. Int J Cardiol. 2011; 150: 332–337.
16.
KonfinoJFerranteDMejiaRCoxsonPMoranAGoldmanL, et al. Impact on cardiovascular disease events of the implementation of Argentina’s national tobacco control law. Tob Control. 2014; 23: e6.
17.
SalgadoMVPenkoJFernandezAMejiaR. Modelling the impact of plain packaging of tobacco products on cardiovascular disease in Argentina. Tob Control. Epub ahead of print 13 July 2021. DOI: 10.1136/tobaccocontrol-2021-056651.
18.
KonfinoJFernandezAPenkoJMasonAMartinezECoxsonP, et al. Comparing strategies for lipid lowering in Argentina: an analysis from the CVD Policy Model - Argentina. J Gen Intern Med. 2017; 32: 524–533; En imprenta.
19.
SalgadoMVPenkoJFernandezAKonfinoJCoxsonPGBibbins-DomingoK, et al. Projected impact of a reduction in sugar-sweetened beverage consumption on diabetes and cardiovascular disease in Argentina: a modeling study. PLoS Med. 2020; 17: e1003224.
20.
MoranACoxsonPFerranteDKonfinoJMejíaRFernandezA, et al. The cardiovascular disease policy model: using a national cardiovascular disease simulation model to project the impact of national dietary salt lowering programs. In: LegeticBCecchiniM (eds). Applying Modeling to Improve Health and Economic Policy Decisions in the Americas: The Case of Noncommunicable Diseases. Pan American Health Organization, OECD; 2015, pp.59–73. Disponible en: http://iris.paho.org/xmlui/bitstream/handle/123456789/7700/9789275118658_eng.pdf?sequence=5
21.
SalgadoMVCoxsonPKonfinoJPenkoJIrazolaVGutierrezL, et al. Update of the cardiovascular disease policy model to predict cardiovascular events in Argentina. Medicina. 2019; 79: 448–444.
22.
García MartíSSotoNCiapponiAPalaciosARodríguezBAlcarazA, et al. Prohibición de publicidad, promoción y patrocinio del tabaco: Paquete de evidencia para la implementación de políticas de control del tabaquismo en Argentina. Documento técnico IECS N° 24 Instituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina. Junio 2017.
23.
BardachAAlcarazARobertiJCiapponiAAugustovskiFPichon-RiviereA.Optimizing tobacco advertising bans in seven Latin American countries: microsimulation modeling of health and financial impact to inform evidence-based policy. Int J Environ Res Public Health. 2021; 18: 5078.
24.
Framingham Heart Study CD-ROM. Washington, DC: Department of Health and Human Services; 2005.
25.
ParishSCollinsRPetoRYoungmanLBartonJJayneK, et al. Cigarette smoking, tar yields, and non-fatal myocardial infarction: 14,000 cases and 32,000 controls in the United Kingdom. The International Studies of Infarct Survival (ISIS) Collaborators. BMJ. 1995; 311: 471–477.
26.
LawMRMorrisJKWaldNJ.Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. BMJ. 1997; 315: 973–980.
27.
BlecherE.The impact of tobacco advertising bans on consumption in developing countries. J Health Econ. 2008; 27: 930–942.
28.
SafferH.Tobacco advertising and promotion. In: JhaPChaloupkaF (eds). Tobacco Control in Developing Countries. New York, NY: Oxford University Press; 2000, pp.213–236.
29.
BraunSKollath-CattanoCBarrientosIMejíaRMorelloPSargentJD, et al. Assessing tobacco marketing receptivity among youth: integrating point of sale marketing, cigarette package branding and branded merchandise. Tob Control. 2016; 25: 648–655.
30.
MinterDJMejiaRSalasIThrasherJPerez-StableEJ.Tobacco point-of-sale advertising in downtown Buenos Aires, Argentina and compliance with the new tobacco advertising restrictions. Tob Control. 2017; 26: 239–240.
MorelloPOndarsuhuDGalanteMO’DonnellVKonfinoJ.Exposición a la publicidad del tabaco en los puntos de venta en Argentina. Evidencias de la Encuesta Nacional de Factores de Riesgo de 2013. Salud Pública Méx. 2017; 59 (Suppl 1): S97–S104.
33.
MejiaRSchojVBarnoyaJFloresMPerez-StableE.Tobacco industry strategies to obstruct the FCTC in Argentina. CVD Prev Control2008; 3: 173–179.
34.
BarnoyaJGlantzS.Tobacco industry success in preventing regulation of secondhand smoke in Latin America: the Latin Project. Tob Control. 2002; 11: 305–314.
35.
HiilamoHGlantzS.FCTC followed by accelerated implementation of tobacco advertising bans. Tob Control. 2017; 26: 428–433.
36.
MirzaM.Advertising restrictions and market concentration in the cigarette industry: a cross-country analysis. Int J Environ Res Public Health. 2019; 16: 3364.
37.
KonfinoJDe MaioFOndarsuhuDGoldbergLLinetzkyBFerranteD.The sociodemographic patterning of opposition to raising taxes on tobacco and restricting tobacco advertisements in Argentina. Public Health. 2015; 129: 364–369.
38.
Cortes-BergoderiMThomasRJAlbuquerqueFNBatsisJABurdiatGPerez-TerzicC, et al. Validity of cardiovascular risk prediction models in Latin America and among Hispanics in the United States of America: a systematic review. Rev Panam Salud Publica. 2012; 32: 131–139.
39.
D’AgostinoRGrundySSullivanLMWilsonP; CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001; 286: 180–187.
40.
World Health Organization. WHO report on the global tobacco epidemic, 2017. Country profile: Argentina. Geneva: World Health Organization; 2017 [consultado el 17 de agosto del 2019]. Disponible en: https://apps.who.int/iris/handle/10665/255874
ZhaoQMengMKumarRWuYHuangJLianN, et al. The impact of COPD and smoking history on the severity of COVID-19: a systemic review and meta-analysis. J Med Virol. 2020; 92: 1915–1921.
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
